Literature DB >> 12505328

Transporters and xenobiotic disposition.

Richard B Kim1.   

Abstract

Metabolism alone does not adequately account for the observed intersubject variability in drug disposition or response. Carrier-mediated processes, or transporters, are increasingly recognized to be importantly involved in drug absorption, distribution, and excretion. Thus for many drugs, transport and metabolism must be considered together to better predict drug disposition in vivo. Accordingly, this review will outline relevant background information regarding drug transporters and the role of such transporters in the drug disposition process.

Mesh:

Substances:

Year:  2002        PMID: 12505328     DOI: 10.1016/s0300-483x(02)00296-2

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  14 in total

Review 1.  Pharmacogenomics: challenges and opportunities.

Authors:  Dan M Roden; Russ B Altman; Neal L Benowitz; David A Flockhart; Kathleen M Giacomini; Julie A Johnson; Ronald M Krauss; Howard L McLeod; Mark J Ratain; Mary V Relling; Huijun Z Ring; Alan R Shuldiner; Richard M Weinshilboum; Scott T Weiss
Journal:  Ann Intern Med       Date:  2006-11-21       Impact factor: 25.391

Review 2.  Fruit juice inhibition of uptake transport: a new type of food-drug interaction.

Authors:  David G Bailey
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

3.  Screening of the interaction between xenobiotic transporters and PDZ proteins.

Authors:  Yukio Kato; Kazuhiro Yoshida; Chizuru Watanabe; Yoshimichi Sai; Akira Tsuji
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

Review 4.  Safety and efficacy of statins in Asians.

Authors:  James K Liao
Journal:  Am J Cardiol       Date:  2006-12-15       Impact factor: 2.778

5.  Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporter.

Authors:  Glenn W Kaatz; Rama V Thyagarajan; Susan M Seo
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 6.  Human pharmacogenomic variations and their implications for antifungal efficacy.

Authors:  Joseph Meletiadis; Stephen Chanock; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

7.  Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein.

Authors:  Glenn W Kaatz; Fionnuala McAleese; Susan M Seo
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

8.  The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers.

Authors:  Tomonori Tateishi; Masatomo Miura; Toshio Suzuki; Tsukasa Uno
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

9.  Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil.

Authors:  Takashi Sakugawa; Masatomo Miura; Nobuo Hokama; Toshio Suzuki; Tomonori Tateishi; Tsukasa Uno
Journal:  Br J Clin Pharmacol       Date:  2009-01-23       Impact factor: 4.335

10.  ABCB1 transporter and Toll-like receptor 4 in trabecular meshwork cells.

Authors:  Algis Grybauskas; Tomoyo Koga; Paulius V Kuprys; Michael Nolan; Ryan McCarty; Loyal Walker; Kelsey A Green; William M Norkett; Beatrice Y J T Yue; Paul A Knepper
Journal:  Mol Vis       Date:  2015-03-05       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.